Jump to content

Gregory Stock

From Wikipedia, the free encyclopedia
Gregory Stock
CitizenshipAmerican
EducationJohns Hopkins University (BA, MSc, PhD)
Harvard Business School (MBA)
Occupation(s)Biophysicist, Bioethicist, Author, and Biotechnology Entrepreneur
Years active1971-Present
Websitehttps://www.gregorystock.net/

Gregory Stock (born 1949) is an American biophysicist, bioethicist, author, and biotechnology entrepreneur. He is renowned for his work on the ethical, social, and evolutionary implications of emerging biotechnologies, particularly in genetics and human enhancement. Stock is the co-founder and former CEO of Signum Biosciences and has held academic positions at institutions including the University of California, Los Angeles (UCLA) and the Icahn School of Medicine at Mount Sinai. brainpreservation.org+3Wikipedia+3Wikipedia – Die freie Enzyklopädie+3

Early life and education

[edit]

Stock earned his Bachelor of Arts (BA) and Master of Science (MSc) degrees in biophysics from Johns Hopkins University in 1971. He completed his PhD in biophysics at the same institution in 1977. Later, he obtained a Master of Business Administration (MBA) from Harvard Business School in 1987, where he was recognized as a Baker Scholar and received the Freund-Porter Entrepreneurship Award. Wikipedia – Die freie Enzyklopädie+1Wikipedia+1Wikipedia

Academic and professional career

[edit]

UCLA Program on Medicine, Technology and Society

[edit]

In 1997, Stock founded the Program on Medicine, Technology and Society at UCLA's School of Medicine and served as its director for a decade. The program aimed to explore the societal and policy implications of advancements in molecular genetics and bioinformatics. Through symposia, lectures, and media engagements, Stock facilitated public discourse on topics such as human germline engineering and life extension. Wikipédia, a enciclopédia livre+6brainpreservation.org+6thekeynotecurators.com+6

Mount Sinai School of Medicine

[edit]

Stock has served as an adjunct professor at the Icahn School of Medicine at Mount Sinai in New York, where he co-directed the Harris Center for Precision Wellness. His work there focused on developing next-generation approaches to wellness and healthcare. covisible.org+1thekeynotecurators.com+1thekeynotecurators.com+1covisible.org+1

Biotechnology Entrepreneurship

[edit]

Stock co-founded Signum Biosciences, a biotechnology company dedicated to developing small-molecule therapeutics targeting signal transduction pathways. The company's research has implications for treating conditions such as Alzheimer's disease, Parkinson's disease, diabetes, asthma, and certain skin disorders. Wikipedia+1brainpreservation.org+1

Publications

[edit]

Stock has authored several books addressing the intersection of biotechnology, ethics, and human evolution:Wikipedia – Die freie Enzyklopädie

The Book of Questions series has sold over 2.5 million copies, been translated into 22 languages, and had over 100 printings.

Public engagement and media

[edit]

Stock is a frequent speaker at academic, governmental, and industry conferences, addressing topics such as personalized medicine, genomics, and the future of biotechnology. He has appeared on various media platforms, including CNN, PBS, NPR, and the BBC, contributing to discussions on the ethical dimensions of scientific advancements. Wikipedia

Honors and recognition

[edit]
[edit]

References

[edit]